NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation
- 29 September 2014
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 34 (29) , 3780-3790
Abstract
Breast cancer is genetically heterogeneous, and recent studies have underlined a prominent contribution of epigenetics to the development of this disease. To uncover new synthetic lethalities with known breast cancer oncogenes, we screened an epigenome-focused short hairpin RNA library on a panel of engineered breast epithelial cell lines. Here we report a selective interaction between the NOTCH1 signaling pathway and the SUMOylation cascade. Knockdown of the E2-conjugating enzyme UBC9 (UBE2I) as well as inhibition of the E1-activating complex SAE1/UBA2 using ginkgolic acid impairs the growth of NOTCH1-activated breast epithelial cells. We show that upon inhibition of SUMOylation NOTCH1-activated cells proceed slower through the cell cycle and ultimately enter apoptosis. Mechanistically, activation of NOTCH1 signaling depletes the pool of unconjugated small ubiquitin-like modifier 1 (SUMO1) and SUMO2/3 leading to increased sensitivity to perturbation of the SUMOylation cascade. Depletion of unconjugated SUMO correlates with sensitivity to inhibition of SUMOylation also in patient-derived breast cancer cell lines with constitutive NOTCH pathway activation. Our investigation suggests that SUMOylation cascade inhibitors should be further explored as targeted treatment for NOTCH-driven breast cancer.Keywords
This publication has 53 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cellsMethods, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Notch Inhibition as a Promising New Approach to Cancer Therapy2012
- Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancerNature Medicine, 2011
- A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancerNature Chemical Biology, 2011
- Synthetic lethality: General principles, utility and detection using genetic screens in human cellsFEBS Letters, 2010
- Direct inhibition of the NOTCH transcription factor complexNature, 2009
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009